• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Biotech Market
Biotech News
Biotech Stocks
  • Biotech Market
  • Biotech News
  • Biotech Stocks

Naturally Splendid Announces Re-assignment of Director to Advisory Board

Matthew Spizziri
Feb. 26, 2016 11:20AM PST
Biotech Investing

Naturally Splendid (TSXV:NSP) announced that Mr. Charlie Brink has stepped down from the Board of Directors and has been assigned to the Naturally Splendid Advisory Board where he will focus on advancing a wide spectrum of technologies focused on commercializing cannabinoid opportunities.

Naturally Splendid (TSXV:NSP) announced that Mr. Charlie Brink has stepped down from the Board of Directors and has been assigned to the Naturally Splendid Advisory Board where he will focus on advancing a wide spectrum of technologies focused on commercializing cannabinoid opportunities.
As quoted in the press release:

This assignment to the Advisory Board, allows Mr. Brink to focus on advancing cannabinoid technologies that his company, Full Spectrum Laboratories Limited, has been advancing over the past several years.
As a member of the Naturally Splendid Advisory Board, Mr. Brink will continue to provide Naturally Splendid with strategic advice in connection with HempOmega™ and the cannabinoid technologies licensed under the restated and amended license agreement (the “Restated and Amended License Agreement”) between Naturally Splendid and Full Spectrum Laboratories Limited (“FSL”), as announced in the September 23, 2015 news release.

Naturally Splendid CEO, Craig Goodwin, stated:

FSL has made significant advancements in the area of advanced cannabinoid technologies that requires much more of Mr. Brink’s attention. The benefit to Naturally Splendid is that we have certain rights to the advancements made on the technologies that FSL are funding. In short, FSL has taken the initiative to advance these technologies while assuming the financial responsibilities associated with the research and development and Naturally Splendid will receive certain benefits of the improvements made to these technologies.

Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.

board of directors
The Conversation (0)

Go Deeper

AI Powered

Naturally Splendid Provides a Coronavirus Update

Naturally Splendid Launches NATERA FX for Practitioner Market

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Biotech Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES